alpha-N-acetylglucosaminidase

临床试验

计划入组 4 人 · 首次发布于 2017 年 10 月 3 日

已完成

NCT06650384

Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity

计划入组 180 人 · 首次发布于 2024 年 10 月 21 日

尚未招募

NCT07157722

Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia

计划入组 66 人 · 首次发布于 2025 年 9 月 5 日

药物

查看全部 3156 →

JR-446

生产企业：JCR Pharmaceuticals Co., Ltd.

相关疾病：mucopolysaccharidosis type IIIB, Sanfilippo syndrome type B

Biotech

Investigational

Lesinidase alfa

Biotech

Investigational

Tralesinidase alfa

机构

查看全部 100 →

N&N Pharmaceuticals, Inc.

United States

Alpha Metallurgical

United States

Zeno Alpha, Inc.

United States

资讯

查看全部 2614 →

4天前

MEDIPAL and JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome Type B

7个月前

Spruce Biosciences Reports Six-Year Data Showing Tralesinidase Alfa Preserves Cognitive Function in Sanfilippo Syndrome Type B

去年

临床试验

Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome

Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity

Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia

药物

JR-446

Lesinidase alfa

Tralesinidase alfa

机构

N&N Pharmaceuticals, Inc.

Alpha Metallurgical

Zeno Alpha, Inc.

资讯

MEDIPAL and JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome Type B

Spruce Biosciences Reports Six-Year Data Showing Tralesinidase Alfa Preserves Cognitive Function in Sanfilippo Syndrome Type B

Spruce Biosciences Reports Breakthrough Long-Term Data for TA-ERT in Rare Sanfilippo Syndrome Type B